Low hepatitis B surface antigen at baseline and increased ALT levels during treatment predicts significant HBsAg decline in peginterferon alfa added to long-term nucleus(t)ice analogue. Results from two randomized controlled trials in 165 patients

Autor:	Mina Farag, Hannah S.J. Choi, Scott Fung, Heng Chi, Margo J.H. van Campenhout, Seng Liem, Qing Xie, Milan Sonneveld, David Wong, Jordan Feld, Karel J. van Erpecum, Robert De Man, Bettina Hansen, Harry Janssen
Rok vydání:	2020
Předmět:	Hepatology
Zdroj:	Journal of Hepatology. 73:S877-S878
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(20)32195-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7763446d3393e0bea529490cef810668 https://doi.org/10.1016/s0168-8278(20)32195-4 Zobrazit plný text záznamu Full Text from ScienceDirect